Abstract:This research presents the innovative CRISPR‐ADAReader system, designed to enable precise manipulation of cell activity through RNA sensing. The system incorporates both positive and negative feedback loops, facilitating tailored regulation across various cell types in a single platform. It demonstrates exceptional programmability, specificity, and sensitivity, offering a powerful tool for the customized and precise control of cellular behavior. In the realms of bioengineering and biopharmaceuticals, there exists a critical demand for advanced genetic tools that can interact with specific cell signaling pathways to accurately identify and target various cell types. This research introduces the innovative CRISPR‐ADAReader system, which enables precise manipulation of cell activity through sensing target RNA. Featuring both positive and negative feedback loops, the system allows for tailored regulation across different cell types in response to various internal signals, showcasing exceptional programmability, specificity, and sensitivity. By choosing distinct RNAs as activation signals, the CRISPR‐ADAReader efficiently monitors and alters targeted cell behaviors. In a case study focusing on retinoblastoma treatment, the system distinctively initiates positive feedback and self‐silencing actions by detecting MCYN and Rb transcripts, thus safeguarding normal retinal pigment epithelial cells while promoting apoptosis in cancer cells. Moreover, the CRISPR‐ADAReader demonstrates significant anti‐tumor effectiveness in live models, markedly reducing retinoblastoma cell proliferation through the activation of several cancer‐suppression pathways, outperforming the capabilities of the ADAR‐sensor. Notably, the system also shows an excellent in vivo safety profile. In conclusion, the CRISPR‐ADAReader system represents a groundbreaking method for the detection and editing of RNA, offering a potent instrument for the customized and precise governance of cell behavior.

RNA-guided cell targeting with CRISPR/RfxCas13d collateral activity in human cells

Collateral Activity of the CRISPR/RfxCas13d System in Human Cells.

Precise transcript targeting by CRISPR-Csm complexes

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Cas9-cleavage sequences in minimal plasmids enhance non-viral genome targeting of CARs in primary human T cells

Abstract 2949: A flexible and efficient approach for single-cell CRISPR perturbation screens combined with targeted RNA-seq expression analysis

Programmable RNA targeting with CRISPR-Cas13

Precision Control of Cell Type‐Specific Behavior via RNA Sensing and Editing

Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Low copy CRISPR-Cas13d mitigates collateral RNA cleavage

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11

Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq

DNA-guided CRISPR/Cas12 for RNA targeting

Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the EML4-ALK Transcript in H3122 Lung Cancer Cells

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

The Collateral Activity of RfxCas13d Can Induce Lethality in a RfxCas13d Knock-in Mouse Model

Intrinsic targeting of host RNA by Cas13 constrains its utility

RNA-Activated CRISPR/Cas12a Nanorobots Operating in Living Cells

Targeting cellular mRNAs translation by CRISPR-Cas9